Importer of Controlled Substances Application: Noramco, Inc., 5810 [2018-02646]

Download as PDF 5810 Federal Register / Vol. 83, No. 28 / Friday, February 9, 2018 / Notices Dated: February 2, 2018. Susan A Gibson, Deputy Assistant Administrator. In accordance with 21 CFR 1301.34(a), this is notice that on July 6, 2017, Noramco, Inc., 1550 Olympic Drive, Athens, Georgia 30601 applied to be registered as an importer of the following basic controlled substances: [FR Doc. 2018–02637 Filed 2–8–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Controlled substance Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Noramco, Inc. ACTION: Notice of application. Registered bulk manufacturer of the affected basic classes and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 12, 2018. Such persons may also file a written request for a hearing on the application on or before March 12, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007). SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. sradovich on DSK3GMQ082PROD with NOTICES DATES: VerDate Sep<11>2014 16:57 Feb 08, 2018 Jkt 244001 Marihuana Extract ........ Marihuana ..................... Tetrahydrocannabinols Nabilone ....................... Phenylacetone .............. Thebaine ....................... Opium, raw ................... Poppy Straw Concentrate. Tapentadol .................... Drug code Schedule 7350 7360 7370 7379 8501 9333 9600 9670 I I I II II II II II 9780 II The company plans to import phenylacetone (8501), opium, raw (9600), and poppy straw concentrate (9670) to bulk manufacture other controlled substances for distribution to its customers. The company plans to import an intermediate form of tapentadol (9780) to bulk manufacture tapentadol (9780) for distribution to its customers. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: January 31, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018–02646 Filed 2–8–18; 8:45 am] BILLING CODE 4410–09–P Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on November 13, 2017, INSYS Manufacturing LLC, 811 Paloma Drive, Suite C, Round Rock, TX 78665–2402 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Marihuana ..................... Tetrahydrocannabinols Drug code 7360 7370 Schedule I I The company plans to manufacture the above listed controlled substances in bulk for distribution to its customers. In reference to drug codes 7360 (marihuana), and 7370 (THC), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration. Dated: January 31, 2018. Susan A. Gibson, Deputy Assistant Administrator. DEPARTMENT OF JUSTICE Drug Enforcement Administration [FR Doc. 2018–02643 Filed 2–8–18; 8:45 am] BILLING CODE 4410–09–P [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: INSYS Manufacturing LLC ACTION: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 10, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 Drug Enforcement Administration [Docket No. DEA–392] Notice of application. DATES: DEPARTMENT OF JUSTICE Importer of Controlled Substances Application: Meridian Medical Technologies Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the DATES: E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 83, Number 28 (Friday, February 9, 2018)]
[Notices]
[Page 5810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02646]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Noramco, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturer of the affected basic classes and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before March 12, 2018. Such 
persons may also file a written request for a hearing on the 
application on or before March 12, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. Comments and requests for hearings on 
applications to import narcotic raw material are not appropriate. 72 FR 
3417 (January 25, 2007).

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on July 
6, 2017, Noramco, Inc., 1550 Olympic Drive, Athens, Georgia 30601 
applied to be registered as an importer of the following basic 
controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana Extract......................     7350  I
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
Nabilone...............................     7379  II
Phenylacetone..........................     8501  II
Thebaine...............................     9333  II
Opium, raw.............................     9600  II
Poppy Straw Concentrate................     9670  II
Tapentadol.............................     9780  II
------------------------------------------------------------------------

    The company plans to import phenylacetone (8501), opium, raw 
(9600), and poppy straw concentrate (9670) to bulk manufacture other 
controlled substances for distribution to its customers. The company 
plans to import an intermediate form of tapentadol (9780) to bulk 
manufacture tapentadol (9780) for distribution to its customers. 
Placement of these drug codes onto the company's registration does not 
translate into automatic approval of subsequent permit applications to 
import controlled substances. Approval of permit applications will 
occur only when the registrant's business activity is consistent with 
what is authorized under 21 U.S.C. 952(a)(2). Authorization will not 
extend to the import of FDA approved or non-approved finished dosage 
forms for commercial sale.

    Dated: January 31, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-02646 Filed 2-8-18; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.